Commercialization: Page 87
-
PharmaVoice Team/PharmaVoice
Going "Live" in the Digital Age
26 September 2008 VIEW on Marketing EDUCATIONAL MARKETING An often asked question is whether the popularity of “going digital” — beaming images across the Internet — will spell the end of live presentations in the pharmaceutical industry. The answer, in a word, is “no.” Using digital media can en...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Adapting to the Changing Healthcare Marketplace
VIEW on Marketing September 2008 CUSTOMERCENTRIC MARKETING Since its inception, the pharmaceutical industry has achieved tremendous success on a variety of levels. It has provided revolutionary clinical advances in a great many therapeutic areas. However, in recent years the success of pharmaceut...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Focusing on the Physician-Patient Dialogue
24 September 2008 VIEW on Marketing CUSTOMERCENTRIC MARKETING Patient adherence is an area that pharmaceutical marketers struggle with on a daily basis. Despite best efforts, many patients do not take their medications as directed. In fact, no therapeutic category is immune — all suffer from this...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
I Guess We Are Going to Have to Create a Brand After All
22 September 2008 VIEW on Marketing CREATIVE Let’s face it: marketing pharmaceuticals just ain’t what it used to be. Gone are the glorious days of blockbusters, problems solved before we even knew they existed, and doctors who controlled the products being used. Today, we have payers who tell doc...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
The Road to Success Patient-Centric Approaches Across the Brand Journey
20 September 2008 VIEW on Marketing COMMERCIAL EFFECTIVENESS Spotting continuity errors in films — such as when a character’s hairstyle changes inexplicably in the middle of a scene — can be rather amusing, and there are now entire websites devoted to sharing these little anomalies. But continuit...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Recontextualization
18 September 2008 VIEW on Marketing BRAND POSITIONING It has already been nearly a decade since Malcolm Gladwell’s book, “The Tipping Point: How Little Things Can Make a Big Dif ference,” made such a huge impact on marketers. In his break through book, Gladwell devoted two chapters to explaining ...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
The Six Step Blockbuster Marketing Recovery Program
16 September 2008 VIEW on Marketing BRAND OPPORTUNITIES The days of legendary blockbuster launches and their massive budgets are fewer and farther between in the present. The party is pretty much over. As trends indicate, we are shifting from a blockbuster model of primary care, single indication...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Supplier Showcase
Showcase 46 September 2008 VIEW on Marketing AmerisourceBergen Specialty Group AmerisourceBergen Corp. 3101 Gaylord Pkwy. Frisco, TX 75034 Phone: 8664083761 www.absg.com The Specialty Pharmaceutical Industry’s Essential Business Partner For pharmaceutical manufacturers, healthcare organizations, ...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Now, 50 years later, David Norton, company group chairman of Johnson & Johnson’s pharmaceuticals group, said in the organization’s July statement: “Doctors rely on accurate and appropriate information about new medicines to provide the best possible care to their patients. The changes to the ...
By PharmaVoice Team • Sept. 16, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
4 September 2008 PharmaVOICE Leveraging Postapproval Research The postapproval landscape has changed for pharmaceutical manufacturers. Craig Eslinger of PPD addresses how data obtained in postmarketing safety surveillance can be used to a company’s advantage. 46 The Growing Influence of Global Pa...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
DIA 2008 — Annual Conference
DIA 2008 DIA ADDRESSES SAFETY TOPICS The 44th Annual Meeting of the Drug Information Association Industry Thought Leaders Raise their VOICE at DIA David Williams of Clinsys discusses what he believes the industry’s biggest challenges are. Imperial’s Bob McGrath identifies risk mitigation as one o...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
The Growing Influence of Global Payers
Managed MARKETS The balance of power is shifting. Global payers are now demanding more data about the cost effectiveness of prescription drugs. And experts say they will continue to do so.Driving the increas ing use of health technology assessments (HTA) by governments to make reimbursement, and ...
By Denise Myshko • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Leveraging Postapproval Research
Only a few short years ago, both product management and product marketing were considered relatively straightforward and uncomplicated activities. Sales representatives were more likely to have greater access to physicians and healthcare providers, and fewer restrictions were placed on marketing ...
By Craig Eslinger • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Last Word
Jason Cohen joined GE Healthcare Financial Services in 2006 and is a Senior VP and Pharmaceuticals Analyst. In this role, he helps lead the GE corporate finance efforts within specialty pharma, generics, biotechnology, and outsourced services. Additionally, he provides guidance and oversight on v...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Brian AYRES Jason CARLIN Dr. Maria DEUTSCH Susan GITTLE Megahn HALLAHAN Chris MARQUES Cynthia SCHWALM Anjali SHAH Staff Changes at Eisai’s North America Operations Eisai Corporation of North America has announced one staff addition at its headquar ters and a number of new hires and pr...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
4th Integrating Electronic Health Records and eClinical Technologies Conference Baltimore Marriott Waterfront Hotel,Baltimore For more information, contact Jasmaine John, ExL Pharma,at 2124006235, email [email protected], or visit exlpharma.com. September 1516 Biotech Patents Royal Sonesta Hote...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
What's New
WHAT’S NEW NEW HEALTH CARE RELATED PRODUCTS, SERVICES, AND COMPANIES IMS Health has joined with 10 leading U.S. academic researchers in medicine, health economics, and public health to establish the Health Services Research Network (HSRN), a consortium that will apply IMS’s evidence based informa...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
“The neurotechnology industry made substan tial gains in 2007, which has continued into 2008,” says Casey Lynch, managing director of Neuro Insights. Neuro Insights found that in 2007, global neurotech industry revenue rose 8.3% to $130.5 billion. Of the industry’s three segments, Neuro pharmaceu...
By PharmaVoice Team • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
The words “corporate social responsibility” are flooding the headlines. While not a new concept, in today’s world there is a fundamental expectation that we should do business in an ethical manner that supports the wellbeing and betterment of society. Under constant scrutiny by industry regulator...
By William Clapper • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
As the summer comes to an end and the hint of fall enters the air, this September issue brings you articles as fresh as a fine Macoun — or Red Delicious, if you prefer. Hard to believe, but yes 2008 is rapidly coming to a close. We thought it was an appropriate time to take inventory of several t...
By Taren Grom • Aug. 27, 2008 -
PharmaVoice Team/PharmaVoice
Incorporating Universal Needs Assessments In CME Planning: Benefits of the 1,000-Foot View
2008 VIEW on Medical Education NEEDS ASSESSMENT A comprehensive needs assessment is the first critical step in planning a CME/CE certified activity, because it becomes the foundation on which every step in the planning process is built. Discussions at recent industry meetings, such as the Allianc...
By PharmaVoice Team • Aug. 20, 2008 -
PharmaVoice Team/PharmaVoice
Evidence-Based CME That Delivers
2008 VIEW on Medical Education EVIDENCE BASED CME CME2 Since 2002, when the AAFP established criteria for evaluating and categorizing the clinical content of CME, providers have been incorporating the principles of evidence based medicine (EBM) into their programs — with varying degrees of succes...
By PharmaVoice Team • Aug. 20, 2008 -
PharmaVoice Team/PharmaVoice
Proving the Value of CME
2008 VIEW on Medical Education BLENDED LEARNING Proving the Value of CME Scott E. Weber Co-CEO William A. Mencia, M.D. Vice President, Education & Medical Affairs Med-IQ The ACCME is mandating that education providers become a bridge to quality healthcare and a partner for change by making ed...
By PharmaVoice Team • Aug. 20, 2008 -
PharmaVoice Team/PharmaVoice
Supplier Showcase
Showcase Cadent Medical Communications Caudex Medical, Inc. Center for Bio-Medical Communication Inc. (CBC) The Center for Biomedical Continuing Education Clinical CONNEXION CME Peer Review LLC CMEpilot cme 2 Communication Science Inc. The Curry Rockefeller Group, LLC ePharmaSolutions Excerpta Me...
By PharmaVoice Team • Aug. 20, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
August 2008 VIEW on Medical Education TABLE OF CONTENTS 3 Letter from the Editor 6 The Forum Medical Education: The Rules Change Again — With Pfizer’s decision to end funding of programs produced by commercial medical education and communications companies, the continuing medical education field ...
By PharmaVoice Team • Aug. 20, 2008
Previous
